The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma

The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma

Cholangiocarcinoma (CCA) is a heterogeneous malignancy with a dismal prognosis. Therapeutic options are largely limited to surgery and conventional chemotherapy offers limited benefit. As immunotherapy has proven highly effective in various cancer types, we have undertaken a quantitative immunohisto...

Full description

Bibliographic Details
Main Authors: Thomas Albrecht, Benjamin Goeppert, Fritz Brinkmann, Alphonse Charbel, Qiangnu Zhang, Johannes Schreck, Nina Wilhelm, Stephan Singer, Bruno C. Köhler, Christoph Springfeld, Arianeb Mehrabi, Peter Schirmacher, Anja A. Kühl, Monika N. Vogel, Holger Jansen, Nalân Utku, Stephanie Roessler
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
immunotherapy
TIRC7
cholangiocarcinoma
immune checkpoint inhibitors
PD-L1
biomarkers
Online Access:https://www.mdpi.com/2072-6694/13/24/6272

Internet

https://www.mdpi.com/2072-6694/13/24/6272

Similar Items